E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 4/22/2015 in the Prospect News PIPE Daily.

Aduro Biotech wraps $25 million private placement of common stock

Company sells 1,470,588 shares at $17.00 per share through offering

By Devika Patel

Knoxville, Tenn., April 22 – Aduro Biotech, Inc. said it completed a $25 million private placement of stock on April 20.

The company sold 1,470,588 common shares at $17.00 apiece. The price per share is 57.5% discount to the April 17 closing share price of $40.00.

The clinical-stage immuno-oncology company is based in Berkeley, Calif.

Issuer:Aduro Biotech, Inc.
Issue:Common stock
Amount:$25 million
Shares:1,470,588
Price:$17.00
Warrants:No
Settlement date:April 20
Stock symbol:Nasdaq: ADRO
Stock price:$40.00 at close April 17
Market capitalization:$13.92 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.